We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





First of Its Kind COVID-19 Facemask Uses Ultraviolet Light to Kill Germs While Leaving Face Uncovered

By HospiMedica International staff writers
Posted on 10 Aug 2020
Engineers at Pavvana (Denver, CO, USA) have developed a revolutionary protective mask that uses ultraviolet light to kill germs while leaving the face uncovered.

Pavvana's next-generation, patent-pending AirShield uses a curtain of air washed through UV-C sterilizing light to protect a user’s personal space at the same time it buffers others from the wearer, all while leaving the face open for work, play and family time. More...
The Pavvana AirShield, worn on the forehead and consisting of UV-C light, air baffles, a rechargeable battery-powered fan and a head strap, is designed to kill 99.99% of airborne viruses and bacteria as the wearer breathes.

The AirShield is the first UV-C powered air shield produced for a mask, potentially replacing cloth and fabric-based face protections that haven't changed in decades. The Pavvana technology uses non-ozone producing UV-C bulbs that are encased so that no light escapes. The AirShield's rechargeable lithium ion battery can provide up to eight hours of comfortable protection, and there's nothing to clean or replace.

"We're excited and honored to bring this innovative, effective and comfortable product out into the world where it belongs," said Pavvana CEO Allbriton Robbins, a longtime designer for Fortune 500 firms. "It's a game-changer at a time when the daily routines of hundreds of millions of people have been torn up by a dangerous virus. We can help."

Related Links:

Pavvana


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Pressure Transducer
TruWave
New
Complete Hip System
Taperloc Complete Hip System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new AI-based method can predict treatment outcomes from health record data (Photo courtesy of 123RF)

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. A new artificial intelligence (AI)-based method has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.